In vitro and in situ studies show a frequent upregulation and activation of STAT3 protein in colorectal cancer (CRC) which is one of the most common carcinomas resulting in high mortality in western countries [17–21]. This evidence concerns the gene STAT3 and colorectal carcinoma.